Atish Dipankar Choudhury

About Atish Dipankar Choudhury

Dr. Choudhury earned a BA in Chemistry from Johns Hopkins University and both an MD and PhD from Columbia University. He completed his residency in Internal Medicine at the Brigham and Women’s Hospital at Harvard Medical School and his clinical fellowship at the Dana-Farber Cancer Institute. He is currently a post-doctoral fellow at the Dana-Farber Cancer Institute and The Broad Institute at Harvard.

Dr. Choudhury is investigating the molecular mechanisms underlying the transition from androgen-dependent to androgen-independent growth in human prostate cancer. He is currently studying several promising candidate genes that were identified through a cDNA library screen. The goal of Dr. Choudhury’s work is to discover new therapeutic targets for patients with castrate resistant prostate cancer.

Dr. William Hahn is Dr. Choudhury’s research mentor. Dr. Hahn is a premier physician scientist and a recipient of the competitive PCF Challenge Award. This award funds a multidisciplinary team focused on discovering inhibitors of the common prostate cancer gene fusion, TMPRSS2:ERG.